ArticleScientific reports2026
Shrimycocin-A, a next generation broad spectrum and systemic biofungicide from coconut shell agro waste for crop protection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The excessive use of chemical fungicides has resulted in severe health and environmental concerns; exploration of sustainable alternatives to the chemical pesticides remains a challenge. In this study we developed a novel bio-fungicide fraction, Shrimycocin-A (Shri-A), obtained from the coconut shells through the process of thermal extraction and activity guided fractionation. The chemical profile of Shri-A was established and physicochemical properties were characterized. Our results demonstrated the superior fungicidal activity of Shri-A (300 µg/ml) against fungicide-tolerant wide-host range phytopathogenic fungi. Shri-A exhibited multiple modes of action, including fungal cell wall disruption, cell membrane depolarization, alteration of ergosterol content, and mitochondrial transmembrane potential. The MIC of Shri-A was ranged between 37.5 and 300 µg/ml and its corresponding MFC was ranged from 75 to 350 µg/ml against different plant and human pathogenic fungi. Shri-A showed systemic absorption, bioavailability without causing phytotoxicity, and acute toxicity to earthworms up to the concentrations 300 µg/ml, 700 µg/ml, and 200 µg/cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.